Vimarsana
Biggest News Aggregation in the World

Page 7 - Cm Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cm Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cm Management Today - Breaking & Trending Today

StockNews.com Begins Coverage on AMCON Distributing (NYSEAMERICAN:DIT) - Vimarsana News

StockNews.com Begins Coverage on AMCON Distributing (NYSEAMERICAN:DIT)

StockNews.com assumed coverage on shares of AMCON Distributing (NYSEAMERICAN:DIT – Free Report) in a research report sent to investors on Saturday. The brokerage issued a hold rating on the stock. Separately, TheStreet downgraded AMCON Distributing from a b- rating to a c rating in a research report on Thursday, January 18th. Get Our Latest Research […]

Pekin Hardy Strauss Inc. Sells 750 Shares of Freeport-McMoRan Inc. (NYSE:FCX) - Vimarsana News

Pekin Hardy Strauss Inc. Sells 750 Shares of Freeport-McMoRan Inc. (NYSE:FCX)

Pekin Hardy Strauss Inc. lessened its position in shares of Freeport-McMoRan Inc. (NYSE:FCX – Free Report) by 1.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 63,890 shares of the natural resource company’s stock after selling 750 shares during the quarter. Pekin Hardy […]

DURECT Co. (NASDAQ:DRRX) Short Interest Down 10.0% in April - Vimarsana News

DURECT Co. (NASDAQ:DRRX) Short Interest Down 10.0% in April

DURECT Co. (NASDAQ:DRRX – Get Free Report) was the recipient of a large decline in short interest in April. As of April 15th, there was short interest totalling 927,500 shares, a decline of 10.0% from the March 31st total of 1,030,000 shares. Based on an average daily volume of 169,000 shares, the short-interest ratio is […]

Pieris Pharmaceuticals (NASDAQ:PIRS) Earns Hold Rating from Analysts at StockNews.com - Vimarsana News

Pieris Pharmaceuticals (NASDAQ:PIRS) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report sent to investors on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of NASDAQ:PIRS opened at $12.04 on Friday. Pieris Pharmaceuticals has a twelve month low of $10.89 and a […]

Source: wkrb13.com
Freeport-McMoRan (NYSE:FCX) Price Target Raised to $54.00 at Raymond James - Vimarsana News

Freeport-McMoRan (NYSE:FCX) Price Target Raised to $54.00 at Raymond James

Freeport-McMoRan (NYSE:FCX – Get Free Report) had its price target hoisted by research analysts at Raymond James from $49.50 to $54.00 in a report released on Wednesday, Benzinga reports. The firm presently has an “outperform” rating on the natural resource company’s stock. Raymond James’ price objective would indicate a potential upside of 13.23% from the […]